DK0970121T3 - Peptidfragmenter af myelin-basisk-protein, deres farmaceutiske sammensætninger og deres anvendelse i behandling af multipel sklerose - Google Patents
Peptidfragmenter af myelin-basisk-protein, deres farmaceutiske sammensætninger og deres anvendelse i behandling af multipel skleroseInfo
- Publication number
- DK0970121T3 DK0970121T3 DK98914725T DK98914725T DK0970121T3 DK 0970121 T3 DK0970121 T3 DK 0970121T3 DK 98914725 T DK98914725 T DK 98914725T DK 98914725 T DK98914725 T DK 98914725T DK 0970121 T3 DK0970121 T3 DK 0970121T3
- Authority
- DK
- Denmark
- Prior art keywords
- mbp
- residues
- levels
- amino acid
- synthetic peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2201841A CA2201841C (en) | 1997-04-04 | 1997-04-04 | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
PCT/CA1998/000290 WO1998045327A1 (en) | 1997-04-04 | 1998-04-03 | Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0970121T3 true DK0970121T3 (da) | 2008-10-20 |
Family
ID=4160340
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03022727T DK1394178T3 (da) | 1997-04-04 | 1998-04-03 | Fremgangsmåde til fastlæggelse af den terapeutiske aktivitet af et MBP-fragment |
DK98914725T DK0970121T3 (da) | 1997-04-04 | 1998-04-03 | Peptidfragmenter af myelin-basisk-protein, deres farmaceutiske sammensætninger og deres anvendelse i behandling af multipel sklerose |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03022727T DK1394178T3 (da) | 1997-04-04 | 1998-04-03 | Fremgangsmåde til fastlæggelse af den terapeutiske aktivitet af et MBP-fragment |
Country Status (21)
Country | Link |
---|---|
EP (2) | EP0970121B1 (da) |
JP (1) | JP4173557B2 (da) |
AT (2) | ATE400582T1 (da) |
AU (1) | AU751303B2 (da) |
CA (2) | CA2201841C (da) |
CY (2) | CY1107445T1 (da) |
CZ (1) | CZ299535B6 (da) |
DE (2) | DE69839163T2 (da) |
DK (2) | DK1394178T3 (da) |
ES (2) | ES2307317T3 (da) |
HK (1) | HK1063805A1 (da) |
HU (1) | HU226768B1 (da) |
NO (1) | NO325018B1 (da) |
NZ (1) | NZ338091A (da) |
PL (1) | PL191965B1 (da) |
PT (2) | PT1394178E (da) |
RO (1) | RO119303B1 (da) |
RU (1) | RU2198893C2 (da) |
SK (1) | SK285815B6 (da) |
UA (1) | UA60331C2 (da) |
WO (1) | WO1998045327A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1541106A (zh) | 2001-06-11 | 2004-10-27 | 转新疗法公司 | 用维生素b12和治疗剂联合治疗病毒性、增殖性和炎性疾病的方法 |
CN101353094B (zh) * | 2008-09-22 | 2011-04-13 | 刘年路 | 密闭瓶状软塑料袋及其应用 |
EA024832B1 (ru) | 2009-10-12 | 2016-10-31 | ЛАЙФБИО ЛАБОРАТОРИС ЭлЭлСи | Олигопептид, связывающий гидролизующие аутоантитела к основному белку миелина mbp, композиции и способ лечения рассеянного склероза |
RU2646817C1 (ru) * | 2016-12-27 | 2018-03-07 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Пептид из состава тяжелой цепи иммуноглобулина человека, пригодный для лечения рассеянного склероза |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2053799C (en) * | 1991-10-22 | 2002-03-12 | Kenneth G. Warren | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
US5817629A (en) * | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
JP3434510B2 (ja) * | 1992-04-09 | 2003-08-11 | オートイミューン インク | ミエリン塩基性タンパク質のペプチドフラグメントを用いたt‐細胞増殖の抑制 |
US5824315A (en) * | 1993-10-25 | 1998-10-20 | Anergen, Inc. | Binding affinity of antigenic peptides for MHC molecules |
EP0787147A1 (en) * | 1994-10-25 | 1997-08-06 | Immulogic Pharmaceutical Corporation | Compositions and treatment for multiple sclerosis |
US6329499B1 (en) * | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
-
1997
- 1997-04-04 CA CA2201841A patent/CA2201841C/en not_active Expired - Fee Related
- 1997-04-04 CA CA002494338A patent/CA2494338C/en not_active Expired - Fee Related
-
1998
- 1998-03-04 UA UA99116049A patent/UA60331C2/uk unknown
- 1998-04-03 AT AT98914725T patent/ATE400582T1/de not_active IP Right Cessation
- 1998-04-03 AT AT03022727T patent/ATE386941T1/de not_active IP Right Cessation
- 1998-04-03 JP JP54217098A patent/JP4173557B2/ja not_active Expired - Fee Related
- 1998-04-03 NZ NZ338091A patent/NZ338091A/en unknown
- 1998-04-03 ES ES98914725T patent/ES2307317T3/es not_active Expired - Lifetime
- 1998-04-03 DK DK03022727T patent/DK1394178T3/da active
- 1998-04-03 EP EP98914725A patent/EP0970121B1/en not_active Expired - Lifetime
- 1998-04-03 PL PL336085A patent/PL191965B1/pl not_active IP Right Cessation
- 1998-04-03 EP EP03022727A patent/EP1394178B1/en not_active Expired - Lifetime
- 1998-04-03 SK SK1329-99A patent/SK285815B6/sk not_active IP Right Cessation
- 1998-04-03 WO PCT/CA1998/000290 patent/WO1998045327A1/en active IP Right Grant
- 1998-04-03 DE DE69839163T patent/DE69839163T2/de not_active Expired - Lifetime
- 1998-04-03 RO RO99-01064A patent/RO119303B1/ro unknown
- 1998-04-03 DE DE69839694T patent/DE69839694D1/de not_active Expired - Lifetime
- 1998-04-03 RU RU99122954/04A patent/RU2198893C2/ru not_active IP Right Cessation
- 1998-04-03 PT PT03022727T patent/PT1394178E/pt unknown
- 1998-04-03 DK DK98914725T patent/DK0970121T3/da active
- 1998-04-03 ES ES03022727T patent/ES2299657T3/es not_active Expired - Lifetime
- 1998-04-03 AU AU69130/98A patent/AU751303B2/en not_active Ceased
- 1998-04-03 CZ CZ0346499A patent/CZ299535B6/cs not_active IP Right Cessation
- 1998-04-03 HU HU0000812A patent/HU226768B1/hu not_active IP Right Cessation
- 1998-04-03 PT PT98914725T patent/PT970121E/pt unknown
-
1999
- 1999-10-01 NO NO19994806A patent/NO325018B1/no not_active IP Right Cessation
-
2004
- 2004-09-01 HK HK04106565A patent/HK1063805A1/xx not_active IP Right Cessation
-
2008
- 2008-04-24 CY CY20081100462T patent/CY1107445T1/el unknown
- 2008-08-05 CY CY20081100818T patent/CY1108239T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ293910A (en) | Peptides useful in immunoregulation of antibodies to human myelin basic protein, pharmaceutical compositions and method of treatment | |
ATE425181T1 (de) | Therapeutische zusammensetzungen aus antikorper und antisens nukleinsäuren gegen serrate | |
ATE108662T1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
AU2750092A (en) | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid | |
CY1108239T1 (el) | Θραυσματα πεπτιδιου της βασικης πρωτεϊνης της μυελινης, οι φαρμακευτικες τους συνθεσεις και η χρηση τους στη θεραπεια της σκληρυνσης κατα πλακας | |
NZ335835A (en) | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients | |
EP0342015A3 (en) | Peptides, their use and pharmaceutical compositions containing them |